Digital Content 
NEWS #PharmaBuzz
17 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/17/3168493/0/en/AKYNZEO-demonstrates-superior-prevention-of-chemotherapy-induced-nausea-and-vomiting-compared-to-the-standard-of-care-in-patients-receiving-moderately-emetogenic-chemotherapy-with-.html
02 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/02/3054025/0/en/Helsinn-Group-submits-a-new-formulation-of-AKYNZEO-to-the-European-Medicines-Agency-EMA.html
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006010/0/en/Helsinn-Group-and-ESTEVE-sign-a-partnership-agreement-renewal-to-commercialize-AKYNZEO-and-ALOXI-in-Germany.html
12 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/12/2897362/0/en/Helsinn-Group-and-Chugai-Pharma-Europe-sign-a-partnership-agreement-renewal-to-commercialize-AKYNZEO-in-the-UK-and-Ireland.html
28 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/11/28/2562924/0/en/Farma-Mondo-Group-and-Helsinn-sign-exclusive-partnership-to-commercialize-AKYNZEO-in-the-Baltic-region.html
18 Sep 2020
// PRESS RELEASE
https://www.helsinn.com/news-and-events/helsinn-group-and-italfarmaco-announce-oral-presentation-of-nepa-netupitant-and-palonosetron-data-at-esmo-virtual-congress-2020/
Share 